• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定出一系列新型的类 flavopiridol 结构作为具有高细胞毒性的激酶抑制剂。

Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency.

机构信息

BioCIS, Equipe Labellisée Ligue Contre le Cancer, Univ. Paris-Sud, CNRS, University Paris-Saclay, F-92290, Châtenay Malabry, France.

Institut de Chimie Organique et Analytique (ICOA), UMR7311 Université d'Orléans-CNRS, Rue de Chartres, BP 6759, 45067, Orléans, Cedex 2, France.

出版信息

Eur J Med Chem. 2020 Aug 1;199:112355. doi: 10.1016/j.ejmech.2020.112355. Epub 2020 May 5.

DOI:10.1016/j.ejmech.2020.112355
PMID:32402934
Abstract

In this work, unique flavopiridol analogs bearing thiosugars, amino acids and heterocyclic moieties tethered to the flavopiridol via thioether and amine bonds mainly on its C ring have been prepared. The analogs bearing thioether-benzimidazoles as substituents have demonstrated high cytotoxic activity in vitro against up to seven cancer cell lines. Their cytotoxic effects are comparable to those of flavopiridol. The most active compound 13c resulting from a structure-activity relationship (SAR) study and in silico docking showed the best antiproliferative activity and was more efficient than the reference compound. In addition, compound 13c showed significant nanomolar inhibition against CDK9, CDK10, and GSK3β protein kinases.

摘要

在这项工作中,我们制备了一系列独特的含有硫代糖、氨基酸和杂环部分的氟维司群类似物,这些类似物通过硫醚键和胺键主要连接在氟维司群的 C 环上。含有硫醚-苯并咪唑取代基的类似物在体外对多达七种癌细胞系表现出高细胞毒性活性。它们的细胞毒性作用与氟维司群相当。通过构效关系(SAR)研究和计算机对接得到的最活性化合物 13c 显示出最佳的抗增殖活性,并且比对照化合物更有效。此外,化合物 13c 对 CDK9、CDK10 和 GSK3β 蛋白激酶表现出显著的纳摩尔抑制作用。

相似文献

1
Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency.鉴定出一系列新型的类 flavopiridol 结构作为具有高细胞毒性的激酶抑制剂。
Eur J Med Chem. 2020 Aug 1;199:112355. doi: 10.1016/j.ejmech.2020.112355. Epub 2020 May 5.
2
Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.新型吡唑并[3,4-d]嘧啶类化合物作为潜在的细胞毒剂:设计、合成、分子对接和 CDK2 抑制。
Anticancer Agents Med Chem. 2019;19(11):1368-1381. doi: 10.2174/1871520619666190417153350.
3
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.新型2-呋喃苯并咪唑类VEGFR-2抑制剂的设计、合成、分子对接及细胞毒性评价
Eur J Med Chem. 2017 Aug 18;136:315-329. doi: 10.1016/j.ejmech.2017.04.068. Epub 2017 Apr 26.
4
Design, synthesis, and primary activity assays of baicalein derivatives as cyclin-dependent kinase 1 inhibitors.白杨素衍生物的设计、合成及作为细胞周期蛋白依赖性激酶 1 抑制剂的初步活性测定。
Chem Biol Drug Des. 2021 Oct;98(4):639-654. doi: 10.1111/cbdd.13917. Epub 2021 Jul 19.
5
Structure-activity relationship studies of flavopiridol analogues.黄酮哌醇类似物的构效关系研究
Bioorg Med Chem Lett. 2000 May 15;10(10):1037-41. doi: 10.1016/s0960-894x(00)00156-6.
6
New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.具有选择性 COX-2 和 EGFR 双重抑制活性的新型噁二唑类化合物:设计、合成、细胞毒性评价及计算机模拟研究。
Eur J Med Chem. 2019 Dec 1;183:111693. doi: 10.1016/j.ejmech.2019.111693. Epub 2019 Sep 10.
7
Triazolopyridazine derivatives: Synthesis, cytotoxic evaluation, c-Met kinase activity and molecular docking.三唑并哒嗪衍生物的合成、细胞毒性评价、c-Met 激酶活性及分子对接研究。
Bioorg Chem. 2019 Nov;92:103272. doi: 10.1016/j.bioorg.2019.103272. Epub 2019 Sep 10.
8
Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition.基于结构的新型吖嗪类似物的设计、合成及潜在选择性激酶抑制的抗肿瘤活性。
Eur J Med Chem. 2018 May 25;152:31-52. doi: 10.1016/j.ejmech.2018.04.029. Epub 2018 Apr 17.
9
Synthesis and identification of unprecedented selective inhibitors of CK1ε.合成并鉴定 CK1ε 的前所未有的选择性抑制剂。
Eur J Med Chem. 2015;96:308-17. doi: 10.1016/j.ejmech.2015.03.046. Epub 2015 Apr 14.
10
Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity.基于汉黄芩素的选择性细胞周期蛋白依赖性激酶 9(CDK9)抑制剂的设计及其在体外和体内抗肿瘤活性。
Eur J Med Chem. 2019 Sep 15;178:782-801. doi: 10.1016/j.ejmech.2019.06.024. Epub 2019 Jun 15.

引用本文的文献

1
New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.两种β-拉帕醌衍生物抗癌作用及毒理基因组安全性的新见解
Pharmaceuticals (Basel). 2025 Jun 3;18(6):837. doi: 10.3390/ph18060837.
2
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.在设计用于抗利什曼原虫治疗的、靶向酪蛋白激酶1的有前景的咪唑并[1,2 - ]吡嗪衍生物时,基于药效团对先导化合物CTN1122进行优化。
RSC Med Chem. 2025 Jun 5. doi: 10.1039/d5md00257e.
3
Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment.
黄酮哌啶醇:一种在癌症治疗中颇具前景的细胞周期蛋白依赖性激酶抑制剂。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3489-3511. doi: 10.1007/s00210-024-03599-2. Epub 2024 Nov 26.
4
Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development.解锁苯并咪唑衍生物的药理潜力:药物开发之路。
Curr Top Med Chem. 2024;24(5):437-485. doi: 10.2174/0115680266283641240109080047.
5
The Pharmacological Implications of Flavopiridol: An Updated Overview. flavopiridol 的药理学意义:最新综述。
Molecules. 2023 Nov 10;28(22):7530. doi: 10.3390/molecules28227530.
6
CDK9 inhibitors in cancer research.癌症研究中的CDK9抑制剂
RSC Med Chem. 2022 Apr 20;13(6):688-710. doi: 10.1039/d2md00040g. eCollection 2022 Jun 22.
7
Chiral Flavonoids as Antitumor Agents.手性黄酮类化合物作为抗肿瘤药物
Pharmaceuticals (Basel). 2021 Dec 5;14(12):1267. doi: 10.3390/ph14121267.
8
Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs.多样性导向合成:以氨基苯乙酮作为天然产物类似物合成的构建模块
Pharmaceuticals (Basel). 2021 Nov 5;14(11):1127. doi: 10.3390/ph14111127.
9
Betulin, a Newly Characterized Compound in Bark, Is a Multi-Target Protein Kinase Inhibitor.桦木醇,一种在树皮中被新鉴定的化合物,是一种多靶点蛋白激酶抑制剂。
Molecules. 2021 Jul 29;26(15):4599. doi: 10.3390/molecules26154599.
10
CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene.CDK10在胃肠道癌症中的双重作用:作为肿瘤抑制因子和癌基因
Front Oncol. 2021 Jun 30;11:655479. doi: 10.3389/fonc.2021.655479. eCollection 2021.